|
- Neuropharmacological characterization
- Receptor binding (dopamine, opioids, cannabinoids, benzodiazepine, NMDA, 5-HT)
- Animal behavioral data
- Neurobehavioral effects
- Discriminative effects (drug discrimination)
- Reinforcing effects (self-administration)
- Physical dependence (withdrawal signs)
- Tolerance
|
|
 |
Service Profile
Download a service profile on Nonclinical Abuse Liability/Drug Dependence Testing.
|
|